Scientifically simple. Creatively efficient.
Our scientific team consists of highly skilled professionals with PhDs, led by a physician who graduated and completed her medical residency at one of the most important medical schools in Brazil, UNIFESP, has clinical research training from Harvard, and over 18 years of experience in the pharmaceutical industry.
Our strategic planning team boasts extensive experience in marketing projects, digital marketing, and branding, gained from working in both agencies and multinational companies.
Our creative team includes writers, designers, and video makers specializing in pharmaceutical marketing and scientific communication, with a wealth of experience across various industries, including pharma and beyond.
Our co-founder Renata is a physician with a degree and medical residency from the Federal University of São Paulo (UNIFESP). She holds an MBA in management from FGV and a specialization in clinical research from the Harvard School of Public Health. Renata worked at Novartis for 10 years in various areas such as Oncology and Primary Care, in different positions: Medical Manager, Head of MSLs and Scientific Communication, Associate Medical Director in Oncology and Cardiometabolism. Since 2017, she has run her own pharmaceutical marketing and scientific communication agency, serving clients such as Aché, Abbvie, Allergan, Bayer, Besins Healthcare, Biogen, BMS, Colgate, Ferring Pharmaceuticals, Libbs, Pfizer, MSD, Novartis, Roche, Sanofi, and other specialized medical professionals and clinics. At KACHI, Renata leads a technical team of scientists, all with PhDs, whose mission is to transform complex technical content into efficient and valuable communication for our clients.
In practice, the challenge in pharmaceutical marketing is not just to build awareness. It is to help physicians move confidently from content exposure to the adoption of new evidence or therapeutic options in clinical practice. That journey has become more complex. Medical education has never been so abundant — or so competitive. The problem […]
For more than two decades, the pharmaceutical industry has invested heavily in collecting, organizing, and analyzing scientific and commercial data. From clinical trial registries to real-world evidence platforms, Pharma has built vast repositories of information.1 But scale is no longer the differentiator. As healthcare grows more complex, regulatory scrutiny intensifies, and therapeutic innovation accelerates, […]
Many of us have experienced something like this. You use an AI system to help prepare a strategic project for the launch of a new medication. At the beginning of the conversation, you provide the following information: “The newly approved indication is for patients at high cardiovascular risk.” Later, you update it: “Actually, the recommendation […]
